SUN PHARMACEUTICAL INDUSTRIES LTD. - Update On US FDA Inspection At Mohali Facility

Download	< Back
13 Aug 2022
This is to inform you that the US FDA conducted an inspection of Mohali manufacturing facility (Punjab, India) of Sun Pharmaceutical Industries Limited ('the Company') from August 3, 2022 to August 12, 2022. At the conclusion of the inspection, the US FDA issued a Form-483, with 6 observations. The Company is preparing the response to the observations, which will be submitted to US FDA within the stipulated timeline.
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us